Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
8
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
8
×
detroit blog main
8
×
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
pfizer
merck
bristol-myers squibb
clinical trials
deals
glaxosmithkline
novartis
roche
abbvie
astrazeneca
biontech
What
bio
roundup
conference
annual
ash
buy
cancer
drug
medical
moves
patients
society
abbvie’s
acquisitions
advantages
alliance
american
appetite
bar
barbecuing
barcelona
becker
biggest
billions
black
blood
borne
bread
brings
bristol
build
butter
buyout
calls
camping
cancers
cardiologist
cash
center
ceo
Language
unset
Current search:
amgen
×
cancer
×
" detroit blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More